1. Executive Summary
1.1 Review of the Pharmaceutical Anti-counterfeiting Technologies Market
1.2 Aims, Scope and Format of Report
1.3 Research and Analysis Methods
2. Introduction to Drug Counterfeiting
2.1 Pharmaceutical Drug Counterfeiting
2.2 The Most Commonly Counterfeited Drugs by Region
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Drugs as Counterfeits
2.3.2 Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 API Legislation
2.4 How Are Drugs Counterfeited?
2.4.1 Why Are Drugs Counterfeited?
2.4.2 Methods for Producing Counterfeit Drugs
2.4.3 Moving Counterfeit Drugs into the Supply Chain
2.4.4 The Pharmaceutical Distribution System and Corruption
2.5 Online Pharmacies and Drug Counterfeiting
2.5.1 The Role of Legitimate Online Pharmacies
2.5.2 Verifying the Authenticity of Online Pharmacies
2.6 The Global Costs of Drug Counterfeiting
2.6.1 The Effects of Counterfeit Drugs on Consumers
2.6.2 The Effects of Counterfeit Drugs on Manufacturers
2.6.3 The Effects of Counterfeit Drugs on Healthcare Providers
2.6.4 The Effects of Counterfeit Drugs on Governments
2.6.5 The Effect of Drug Counterfeiting on the Global Pharmaceutical Industry
2.7 What Drives Drug Counterfeiting?
2.7.1 Drug Counterfeiting Thrives on the Lack of Adequate or Enforceable Legislation
2.7.2 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.3 The Inappropriate Use of Drugs Creates a Market for Counterfeiting
2.7.4 High Price Some Medicines Drive People to Cheaper Counterfeit Alternatives
2.7.5 The Trade of Pharmaceuticals Through Several Intermediaries Helps Hide Counterfeit Drugs
2.7.6 Trade Through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.7 Counterfeiters Target Developed Markets
2.7.8 Parallel Trade - a Counterfeiting Route in Europe
3. Leading Technologies and Applications
3.1 Passive Technologies 2012
3.1.1 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Overt and Hidden Imaging
3.1.4 Security Inks as Anti-counterfeiting Technologies
3.2 Active Technologies 2012
3.2.1 Taggants as Anti-counterfeiting Technologies
3.2.2 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
3.2.3 Mass Encoding
3.2.3.1 Barcode Applications - Serialisation is Key
3.2.3.2 Digital Mass Serialisation (DMS)
3.2.3.3 Digital Mass Encryption (DME)
4. Leading Companies in the Field
4.1 3M
4.1.1 The Anti-counterfeiting Solutions of 3M
4.2 Alien Technology - RFID Technology
4.3 AlpVision - Crytptoglyph Security Solution
4.4 Angstrom Technologies - Security Inks
4.5 Authentix - Brand Protection Solutions
4.5.1 The Packaging Solutions of Authentix
4.5.2 Authentix Track-and-Trace Solutions
4.6 Avery Dennison - a Leader in RFID Technologies
4.7 Colorcon
4.7.1 Colorcon Brand Enhancement Service
4.7.2 Colorcon's Taggants: On-Dose ID
4.7.3 Other Identifiers by Colorcon
4.8 Chesapeake - Cortegra Acquisition
4.9 Covectra
4.9.1 Covectra's Authenti-Track Platform
4.10 Everest Holovisions - Holographic Security
4.11 InkSure Technologies - Taggant Technology
4.12 Intermec - Automatic Information Data Capture
4.13 NanoGuardian
4.13.1 The NanoEncryption Process
4.13.2 NanoGuardian Closed-Loop Protection System
4.13.3 NanoGuardian's Global Collaboration Agreement with Capsugel
4.14 Thermo Scientific (Formerly Ahura Scientific and Polychromix)
4.14.1 Thermo Scientific's TruScan Technology
4.15 TruTag Technologies
4.15.1 TruTag's Proprietary Technology
4.16 UPM Raflatac - Smartrac Take Over RFID Business
4.17 Zebra Technologies
5. Global Pharmaceutical Anti-counterfeiting Technologies Market 2012-2022
5.1 Overview of the World Anti-counterfeiting Technologies Market 2011-2022
5.2 Pharmaceutical Security Printing Market Forecast 2012-2022
5.3 Pharmaceutical RFID Market Forecast 2012-2022
5.4 Pharmaceutical Taggants Market Forecast 2012-2022
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2022
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2022
6. Leading National Markets 2012-2022
6.1 The Global Counterfeiting Problem 2011
6.2 Forecasts for the Leading National Markets 2012-2022
6.2.1 US Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.2 Leading European Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.3 Japanese Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.4 Brazilian Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.5 Russian Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.6 Indian Anti-counterfeiting Technologies Market Forecast 2012-2022
6.2.6.1 WHO to Help India Curb Low Quality Medicines
6.2.7 Chinese Anti-counterfeiting Technologies Market Forecast 2012-2022
7. Trends in Pharmaceutical Anti-counterfeiting Technologies 2012-2022
7.1 SWOT Analysis for Pharmaceutical Anti-counterfeiting Technologies 2012-2022
7.1.1 Drivers and Restraints For Pharmaceutical Anti-counterfeiting Technologies 2012-2022
7.2 Market Strengths
7.2.1 Significant Interest from Pharmaceutical Industry in Tackling Counterfeiting
7.2.1.1Pfizer
7.2.1.2 Johnson & Johnson
7.2.1.3 GlaxoSmithKline
7.2.1.4 Sanofi
7.2.1.5 Novartis
7.2.1.6 AstraZeneca
7.2.2 Organisations Tackling Pharmaceutical Counterfeiting
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7.2.2.3 Brazil's National Health Surveillance Agency (ANVISA)
7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
7.2.2.5 Center for Healthcare Supply Chain Research
7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
7.2.2.8 International Anti-counterfeiting Coalition (IACC)
7.2.2.9 International Authentication Association (IAA)
7.2.2.10 The Pharmaceutical Security Institute (PSI)
7.2.3 Manufacturer and Distributor Liability for Counterfeit Products
7.2.4 Increased Supply Chain Efficiency using Track-and-Trace Solutions
7.2.4.1 Potential to Reduce Costs of Pharmaceutical Returns and Recalls
7.2.5 New Technologies are Available
7.3 Market Weaknesses
7.3.1 Unproven Commercial Benefits of Anti-counterfeiting Technologies
7.3.2 Challenges in Proving the Commercial Benefits of Anti-counterfeiting Technologies
7.3.3 Lack of Industry-Wide Standards Will Impede Adoption of Technology
7.3.4 Poor Cooperation Between a Country's Governmental Organisations Aids Drug Counterfeiters
7.3.5 Reliability of Anti-counterfeiting Technology and Integration into Manufacturing Processes
7.4 Market Opportunities and Threats
7.4.1 Developing Countries Will Continue to See High Counterfeit Activity
7.4.2 Counterfeiters - One Step Ahead?
7.4.3 Anti-counterfeiting Technologies to Prevent Online Fraud
7.5 STEP Analysis for Pharmaceutical Anti-counterfeiting Technology 2012-2022
7.6 Social Factors
7.6.1 Public Awareness and Education
7.6.2 Corruption Is a Tool of the Counterfeiter
7.6.3 Security of Information
7.6.4 The Weak Enforcement of Legislation
7.7 Technological Developments
7.7.1 Nanotechnology - Invisible 2D Barcodes
7.7.2 Smartphone Applications and Consumer Empowerment
7.7.3 The US FDA Develops New Detection Device
7.7.4 Bokode - a Replacement for Barcodes?
7.7.5 SigNature DNA
7.8 Economic Pressures
7.8.1 Implementation Costs of Anti-counterfeiting Technologies
7.8.2 Anti-counterfeiting Technologies Require R&D Investment
7.9 Political Issues
7.9.1 Anti-Counterfeiting Trade Agreement (ACTA)
7.9.2 World Health Organization - IMPACT Programme
7.9.3 The Fagan Civil Case
7.9.3.1 Effects of Litigation on Players in the Drug Supply Chain
7.9.4 New Supply Chain Security Legislation
7.9.5 E-pedigree Legislation: US
7.9.5.1 E-pedigree: What Does it Entail?
7.9.5.2 E-pedigree Solutions
7.9.6 European Falsified Medicines Directive
7.9.7 UK MHRA Launches New Anti-counterfeiting Strategy
8. Opinions from Our Survey: Research Interviews
8.1 Interview with Sarah Hein, Marketing Director, InkSure Technologies
8.1.1 Thoughts on the Current Pharmaceutical Counterfeiting Situation
8.1.2 Global Counterfeiting Threats
8.1.3 Combating Pharmaceutical Counterfeiting
8.1.4 Thoughts on Drivers and Threats in the Pharmaceutical Anti-counterfeiting Market
8.2 Interview with Dr Fred Jordan, Co-founder and CEO of AlpVision
8.2.1 The Pharmaceutical Counterfeiting Situation
8.2.2 Pharmaceutical Anti-counterfeiting Technologies
8.2.3 Thoughts on Challenges Facing Anti-counterfeiting Technologies
8.2.4 The Responsibility of Counterfeit Prevention
8.2.5 Thoughts on Anti-counterfeiting Market Drivers
9. Conclusions
9.1 The World Pharmaceutical Anti-counterfeiting Technologies Market 2012-2022
9.2 The US Will Continue to Dominate
9.3 Legislation Will Ensure Track-and-Trace Solutions Remain Market Leaders
9.4 Regulation of Internet Pharmacies Must Improve
9.5 Closing Thoughts on the Industry and Market
List of Tables
Table 1.1 Currency Exchange Rates, 2011
Table 2.1 Worldwide Incidents of Drug Counterfeiting, 2009-2011
Table 2.2 Types of Counterfeit Drugs
Table 3.1 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2012
Table 3.2 Leading Manufacturers of Anti-counterfeiting Security Inks, 2012
Table 3.3 Leading Manufacturers of Pharmaceutical Taggants, 2012
Table 3.4 Leading Manufacturers of RFID Tags, 2012
Table 4.1 Angstrom Technologies Product Range, 2012
Table 4.2 Avery Dennison: Selected RFID Products, 2012
Table 4.3 InkSure Technologies Product Range, 2012
Table 4.4 InkSure Technologies Revenue, 2009-2011
Table 4.5 Selected Intermec Product Lines, 2012
Table 4.6 Intermec Revenue, 2009-2011
Table 4.7 Selected UPM Raflatac Products, 2012
Table 4.8 Zebra Technologies Revenue, 2009-2011
Table 5.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Sector, ($m), AGR (%), CAGR (%), 2011-2022
Table 5.2 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2011, 2017 & 2022
Table 5.3 Security Printing Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.4 RFID Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.5 Taggants Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.6 Hologram/OVD Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.7 Other Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Region, ($m), AGR (%), CAGR (%), 2011-2022
Table 6.2 Pharmaceutical Anti-counterfeiting Technologies: World Market Shares by Region (%), 2011, 2017 & 2022
Table 6.3 US Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.4 EU5 Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.5 Japanese Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.6 Brazilian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.7 Russian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.9 Chinese Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 7.1 Pharmaceutical Anti-counterfeiting Technologies: SWOT Analysis, 2012-2022
Table 7.2 Selected Counterfeiting Activities, 2009-2012
Table 9.1 World Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
List of Figures
Figure 2.1 Worldwide Incidents of Drug Counterfeiting, 2009-2011
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Drugs Entering the Legal Supply Chain
Figure 3.1 Hologram Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.2 Taggant Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.4 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 4.1 InkSure Technologies Revenue, 2009-2011
Figure 4.2 Intermec Revenue, 2009-2011
Figure 4.3 Zebra Technologies Revenue, 2009-2011
Figure 5.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast ($m), 2011-2022
Figure 5.2 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Sector ($m), 2011-2022
Figure 5.3 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2011
Figure 5.4 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2017
Figure 5.5 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2022
Figure 5.6 Security Printing Revenue Forecast ($m), 2011-2022
Figure 5.7 5 RFID Revenue Forecast ($m), 2011-2022
Figure 5.8 Taggants Revenue Forecast ($m), 2011-2022
Figure 5.9 Hologram/OVD Revenue Forecast ($m), 2011-2022
Figure 5.10 Other Revenue Forecast ($m), 2011-2022
Figure 6.1 Pharmaceutical Anti-counterfeiting Incidents by Region (%), 2008 & 2011
Figure 6.2 US, EU5 and Japan: Pharmaceutical Anti-counterfeiting Technologies Forecast ($m), 2011-2022
Figure 6.3 Brazil, Russia, India and China: Pharmaceutical Anti-counterfeiting Technologies Forecast ($m), 2011-2022
Figure 6.4 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2011
Figure 6.5 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2017
Figure 6.6 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2022
Figure 6.7 US Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.8 EU5 Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.9 Japanese Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.10 Brazilian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.11 Russian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.12 Indian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.13 Chinese Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 7.1 Pharmaceutical Anti-counterfeiting Technologies: Drivers, 2012-2022
Figure 7.2 Pharmaceutical Anti-counterfeiting Technologies: Restraints, 2012-2022
Figure 7.3 Anti-counterfeiting Strategies in the US and Europe, 2012
Figure 9.1 World Pharmaceutical Anti-counterfeiting Market Forecast ($m): Total Market, Security Printing and RFID Segments, 2011-2022